Header

UZH-Logo

Maintenance Infos

Serotonin and Schizophrenia


Quednow, Boris B; Geyer, M A; Halberstadt, A L (2009). Serotonin and Schizophrenia. In: Müller, C R; Jacobs, B. Handbook of the Behavioral Neurobiology of Serotonin. London: Academic Press, 585-620.

Abstract

Although the serotonin hypothesis of schizophrenia is one of the oldest neurochemical hypotheses on the pathogenesis of this disease, it is still highly topical. The concept of how the serotonin system is involved in the origin and progress of schizophrenia has considerably changed over the past decades. Therefore, the present work will give an overview about the development and the current directions of the serotonin hypothesis of schizophrenia. In this regard, we will discuss the phenomenology of hallucinogenic drug action, model psychosis and translational research, post-mortem studies on receptors and transporters, imaging studies, antipsychotic drug action, neuroendocrine challenge studies, platelet and cerebrospinal fluid data, genetic association studies, developmental aspects, and the cross-talk between the glutamate and the serotonin system. In sum, there are several lines of evidence suggesting that the serotonin system plays a major role in the pathogenesis of at least a subpopulation of schizophrenia patients. Further studies are needed to better characterize patients whose psychotic symptoms are suspected to have a serotonergic origin.

Abstract

Although the serotonin hypothesis of schizophrenia is one of the oldest neurochemical hypotheses on the pathogenesis of this disease, it is still highly topical. The concept of how the serotonin system is involved in the origin and progress of schizophrenia has considerably changed over the past decades. Therefore, the present work will give an overview about the development and the current directions of the serotonin hypothesis of schizophrenia. In this regard, we will discuss the phenomenology of hallucinogenic drug action, model psychosis and translational research, post-mortem studies on receptors and transporters, imaging studies, antipsychotic drug action, neuroendocrine challenge studies, platelet and cerebrospinal fluid data, genetic association studies, developmental aspects, and the cross-talk between the glutamate and the serotonin system. In sum, there are several lines of evidence suggesting that the serotonin system plays a major role in the pathogenesis of at least a subpopulation of schizophrenia patients. Further studies are needed to better characterize patients whose psychotic symptoms are suspected to have a serotonergic origin.

Statistics

Citations

7 citations in Web of Science®
12 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

546 downloads since deposited on 16 Dec 2009
44 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Book Section, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Psychiatric University Hospital Zurich > Clinic for Psychiatry, Psychotherapy, and Psychosomatics
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:11 December 2009
Deposited On:16 Dec 2009 10:09
Last Modified:24 Sep 2017 05:21
Publisher:Academic Press
Series Name:Handbook of Behavioral Neuroscience
Number:Volume
ISBN:978-0-12-374634-4
Publisher DOI:https://doi.org/10.1016/S1569-7339(10)70102-8
Related URLs:http://www.elsevier.com/wps/find/bookdescription.cws_home/720555/description#description (Publisher)

Download

Download PDF  'Serotonin and Schizophrenia'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher